Rheumatoid Arthritis Exerts Mental and Physical Toll

May 2014
Focus on Healthy Aging;May2014, Vol. 17 Issue 5, p7
The article offers information on rheumatoid arthritis (RA) which is an autoimmune disease that affects joints. Topics discussed include association between depression and RA, treatment for RA and groups of disease-modifying antirheumatic drugs (DMARDs). Also presented are the views of Olivia Ghaw, assistant professor of medicine at the Mount Sinai hospital, on mechanism of RA.


Related Articles

  • Rheumatoid arthritis: chronic, painful, but treatable. Sjoblom, Beth // South County Journal;4/4/2012, Vol. 47 Issue 14, pB2 

    The article discusses the treatment of rheumatoid arthritis, an autoimmune disease that affects 1.3 million of the population in the U.S.

  • Combination therapy for autoimmune diseases: the rheumatoid arthritis model. Fathy, N.; Furst, D.E. // Springer Seminars in Immunopathology;Jun2001, Vol. 23 Issue 1/2, p5 

    Examines the effectiveness of combination therapy for treating autoimmune diseases such as rheumatoid arthritis. Type of medications combined for treating the disease; Mechanisms of action of the combined drugs.

  • Combination therapy in rheumatoid arthritis. Bingham, S.; Emery, P. // Springer Seminars in Immunopathology;Jun2001, Vol. 23 Issue 1/2, p165 

    Reports on the results of using combination therapy in treating autoimmune diseases such as rheumatoid arthritis. Details of clinical experience of the combined therapy; Efficacy of combined MTX and cyclosporin.

  • Management of the Patient with Severe Refractory Rheumatoid Arthritis: Are the Newer Treatment Options Worth Considering? Lacki, J.K. // BioDrugs;2000, Vol. 13 Issue 6, p425 

    Rheumatoid arthritis (RA) is a chronic, inflammatory, autoimmune disease leading to joint destruction. It is the most common cause of potentially treatable disabilities. The outcome of the disease varies from very mild to a refractory, rapidly progressive type with a high mortality rate. In...

  • Editorials: Sulphasalazine in rheumatoid arthritis: an old drug revived. Neumann, V. C.; Grindulis, K. A. // Journal of the Royal Society of Medicine;Mar1984, Vol. 77 Issue 3, p169 

    The article discusses the benefits of sulphasalazine in treating rheumatoid arthritis. Sulphasalazine is an old drug which is a compound of sulphapyridine and 5-aminosalicylic acid linked by an azo bond. The benefits of salicylates in rheumatoid arthritis have an excellent effect on the...

  • EULAR updates recommendations for DMARDs in RA.  // PharmacoEconomics & Outcomes News;Nov2013, Issue 691, p3 

    The article reports that the European League Against Rheumatism (EULAR) has updated its recommendation for the use of disease-modifying antirheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis (RA), aimed at improving outcomes in patients with RA.

  • News update.  // Applied Clinical Trials;Jan2000, Vol. 9 Issue 1, p14 

    Presents news items on applied clinical trials, compiled in January, 2000. Includes United States Food and Drug Administration's approval for the marketing of Centocor's Remicade for the treatment of rheumatoid arthritis unresponsive to methotrexate; Study conducted at Federal University's...

  • IL-17 and its Receptor Complex as Therapeutic Targets in Arthritis. Myew-Ling Toh; Miossec, Pierre // Immunology, Endocrine & Metabolic Agents - Medicinal Chemistry;Sep2008, Vol. 8 Issue 3, p247 

    In addition to TNF and IL-1, IL-17 derived from Th17 cells is a leading cytokine target and has an established key role in adaptive and autoimmune disease such as rheumatoid arthritis (RA). A recent explosion in the literature in the last few years has lead to a renewal of interest in IL-17 as a...

  • Comparison of Treatment Strategies in Early Rheumatoid Arthritis. Goekoop-Ruiterman, Yvonne P. M.; de Vries-Bouwstra, Jeska K.; Allaart, Cornelia F.; van Zeben, Derkjen; Kerstens, Pit J. S. M.; Hazes, J. Mieke W.; Zwinderman, Aelko H.; Peeters, André J.; de Jonge-Bok, Johanna M.; Mallée, Constant; de Beus, Wim M.; de Sonnaville, Peter B. J.; Ewals, Jacques A. P. M.; Breedveld, Ferdinand C.; Dijkmans, Ben A. C. // Annals of Internal Medicine;3/20/2007, Vol. 146 Issue 6, p406 

    Background: In patients with early rheumatoid arthritis, initial combination therapies provide earlier clinical improvement and less progression of joint damage after 1 year compared with initial monotherapies (as demonstrated in the BeSt study). Objective: To evaluate whether the initial...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics